by admin_63069 | Feb 3, 2025 | News You Can Use
It is important to consider disease volume, whether presentation with mCSPC is de novo, presence of comorbid conditions, and eligibility for docetaxel chemotherapy treatment.
by admin_63069 | Jan 29, 2025 | Related Topics
The year 2024 has been transformative for prostate cancer (PCa) and prostatic diseases, marked by advancements in basic science, diagnostic tools and novel therapeutic options.
by admin_63069 | Jan 27, 2025 | News You Can Use
Do they underestimate the risk of biochemical recurrence?
by admin_63069 | Jan 23, 2025 | Resources
WebMD Prostate Cancer Guide
by admin_63069 | Jan 22, 2025 | Related Topics
In this interview, Michael S. Cookson, MD, MMHC, FACS, touches on the current and future applications of PSMA-PET imaging in prostate cancer.
